OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 202
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 202
Showing 26-50 of 202 citing articles:
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 23
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 23
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Sex difference in brain CB1 receptor availability in man
Heikki Laurikainen, Lauri Tuominen, Maria Tikka, et al.
NeuroImage (2018) Vol. 184, pp. 834-842
Open Access | Times Cited: 82
Heikki Laurikainen, Lauri Tuominen, Maria Tikka, et al.
NeuroImage (2018) Vol. 184, pp. 834-842
Open Access | Times Cited: 82
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
Gloria Hernández‐Torres, Mariateresa Cipriano, Erika Hedén, et al.
Angewandte Chemie (2014) Vol. 126, Iss. 50, pp. 13985-13990
Closed Access | Times Cited: 81
Gloria Hernández‐Torres, Mariateresa Cipriano, Erika Hedén, et al.
Angewandte Chemie (2014) Vol. 126, Iss. 50, pp. 13985-13990
Closed Access | Times Cited: 81
Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity
Lingling Sun, Rui Dong, Xin Xu, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 79
Lingling Sun, Rui Dong, Xin Xu, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 79
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis
Andrea Navarria, Alessandra Tamburella, Fabio Arturo Iannotti, et al.
Pharmacological Research (2014) Vol. 87, pp. 151-159
Closed Access | Times Cited: 74
Andrea Navarria, Alessandra Tamburella, Fabio Arturo Iannotti, et al.
Pharmacological Research (2014) Vol. 87, pp. 151-159
Closed Access | Times Cited: 74
Cannabidiol and epilepsy: Rationale and therapeutic potential
Antonio Leo, Emilio Russo, Maurizio Elia
Pharmacological Research (2016) Vol. 107, pp. 85-92
Closed Access | Times Cited: 70
Antonio Leo, Emilio Russo, Maurizio Elia
Pharmacological Research (2016) Vol. 107, pp. 85-92
Closed Access | Times Cited: 70
Cannabis regulatory science: risk–benefit considerations for mental disorders
Jacob T. Borodovsky, Alan J. Budney
International Review of Psychiatry (2018) Vol. 30, Iss. 3, pp. 183-202
Open Access | Times Cited: 68
Jacob T. Borodovsky, Alan J. Budney
International Review of Psychiatry (2018) Vol. 30, Iss. 3, pp. 183-202
Open Access | Times Cited: 68
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
Maria Morena, Kira D. Leitl, Haley A. Vecchiarelli, et al.
Neuropharmacology (2016) Vol. 111, pp. 59-69
Closed Access | Times Cited: 67
Maria Morena, Kira D. Leitl, Haley A. Vecchiarelli, et al.
Neuropharmacology (2016) Vol. 111, pp. 59-69
Closed Access | Times Cited: 67
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review
Maria M. Steenkamp, Esther Blessing, Isaac R. Galatzer‐Levy, et al.
Depression and Anxiety (2017) Vol. 34, Iss. 3, pp. 207-216
Open Access | Times Cited: 67
Maria M. Steenkamp, Esther Blessing, Isaac R. Galatzer‐Levy, et al.
Depression and Anxiety (2017) Vol. 34, Iss. 3, pp. 207-216
Open Access | Times Cited: 67
Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana
Daniel L. Feingold, Silviu Brill, Itay Goor‐Aryeh, et al.
Journal of Affective Disorders (2017) Vol. 218, pp. 1-7
Closed Access | Times Cited: 67
Daniel L. Feingold, Silviu Brill, Itay Goor‐Aryeh, et al.
Journal of Affective Disorders (2017) Vol. 218, pp. 1-7
Closed Access | Times Cited: 67
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
Christopher S. Pauli, Matthieu Conroy, Brian D. Vanden Heuvel, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 66
Christopher S. Pauli, Matthieu Conroy, Brian D. Vanden Heuvel, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 66
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
Claudio D’Addario, Vincenzo Micale, Martina Di Bartolomeo, et al.
Schizophrenia Research (2017) Vol. 188, pp. 132-140
Closed Access | Times Cited: 64
Claudio D’Addario, Vincenzo Micale, Martina Di Bartolomeo, et al.
Schizophrenia Research (2017) Vol. 188, pp. 132-140
Closed Access | Times Cited: 64
Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome
Daniele Vigli, Livia Cosentino, Carla Raggi, et al.
Neuropharmacology (2018) Vol. 140, pp. 121-129
Closed Access | Times Cited: 62
Daniele Vigli, Livia Cosentino, Carla Raggi, et al.
Neuropharmacology (2018) Vol. 140, pp. 121-129
Closed Access | Times Cited: 62
Cannabinoid interventions for PTSD: Where to next?
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 94, pp. 302-320
Closed Access | Times Cited: 59
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 94, pp. 302-320
Closed Access | Times Cited: 59
Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience
Michael C. Flux, Christopher A. Lowry
Neurobiology of Disease (2019) Vol. 135, pp. 104578-104578
Open Access | Times Cited: 55
Michael C. Flux, Christopher A. Lowry
Neurobiology of Disease (2019) Vol. 135, pp. 104578-104578
Open Access | Times Cited: 55
The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice
Shi-Yu Shen, Rui Yu, Wei Li, et al.
Neurobiology of Disease (2022) Vol. 169, pp. 105743-105743
Open Access | Times Cited: 32
Shi-Yu Shen, Rui Yu, Wei Li, et al.
Neurobiology of Disease (2022) Vol. 169, pp. 105743-105743
Open Access | Times Cited: 32
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 28
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 28
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 18
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 18
Potential role of CYP2D6 in the central nervous system
Jie Cheng, Yueying Zhen, Sharon Miksys, et al.
Xenobiotica (2013) Vol. 43, Iss. 11, pp. 973-984
Open Access | Times Cited: 69
Jie Cheng, Yueying Zhen, Sharon Miksys, et al.
Xenobiotica (2013) Vol. 43, Iss. 11, pp. 973-984
Open Access | Times Cited: 69
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
Marta Kruk-Słomka, Agnieszka Michalak, Grażyna Biała
Behavioural Brain Research (2015) Vol. 284, pp. 24-36
Closed Access | Times Cited: 61
Marta Kruk-Słomka, Agnieszka Michalak, Grażyna Biała
Behavioural Brain Research (2015) Vol. 284, pp. 24-36
Closed Access | Times Cited: 61
Development and Validation of a Sensitive UPLC-ESI-MS/MS Method for the Simultaneous Quantification of 15 Endocannabinoids and Related Compounds in Milk and Other Biofluids
Sandra Gouveia‐Figueira, Malin L. Nording
Analytical Chemistry (2013) Vol. 86, Iss. 2, pp. 1186-1195
Closed Access | Times Cited: 61
Sandra Gouveia‐Figueira, Malin L. Nording
Analytical Chemistry (2013) Vol. 86, Iss. 2, pp. 1186-1195
Closed Access | Times Cited: 61
Cannabinoid receptor type 1 receptors on GABA ergic vs. glutamatergic neurons differentially gate sex‐dependent social interest in mice
Ana Luisa B. Terzian, Vincenzo Micale, Carsten T. Wotjak
European Journal of Neuroscience (2014) Vol. 40, Iss. 1, pp. 2293-2298
Closed Access | Times Cited: 61
Ana Luisa B. Terzian, Vincenzo Micale, Carsten T. Wotjak
European Journal of Neuroscience (2014) Vol. 40, Iss. 1, pp. 2293-2298
Closed Access | Times Cited: 61
